Jubilant Life Sciences receives ANDA approval for Olmesartan Medoxomil Tablets

25 Apr 2017 Evaluate

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg, and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension. This is the second approval that the company received from the USFDA during the current financial year. As on December 31, 2016, Jubilant Life Sciences had a total of 73 ANDAs for Oral Solids filed in the US, of which 49 have been approved.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

950.25 -43.35 (-4.36%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×